Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,270 | 959 | 99.5% |
| Education | $75.92 | 12 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,676 | 93 | $0 (2024) |
| ABBVIE INC. | $1,359 | 76 | $0 (2024) |
| PFIZER INC. | $1,245 | 111 | $0 (2024) |
| Novo Nordisk Inc | $1,241 | 89 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,087 | 79 | $0 (2024) |
| Lilly USA, LLC | $751.16 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $572.29 | 47 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $503.99 | 28 | $0 (2024) |
| GlaxoSmithKline, LLC. | $466.31 | 32 | $0 (2024) |
| Merck Sharp & Dohme LLC | $453.82 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,144 | 119 | ABBVIE INC. ($287.68) |
| 2023 | $2,019 | 114 | AbbVie Inc. ($359.47) |
| 2022 | $1,820 | 117 | ABBVIE INC. ($224.13) |
| 2021 | $2,187 | 139 | AbbVie Inc. ($410.94) |
| 2020 | $1,568 | 96 | AstraZeneca Pharmaceuticals LP ($305.86) |
| 2019 | $1,266 | 91 | PFIZER INC. ($289.16) |
| 2018 | $1,654 | 139 | PFIZER INC. ($254.80) |
| 2017 | $1,689 | 156 | AstraZeneca Pharmaceuticals LP ($194.57) |
All Payment Transactions
971 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Biological | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/06/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $19.69 | General |
| Category: Endocrinology | ||||||
| 11/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Obesity | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,029 | 1,479 | $272,267 | $70,857 |
| 2022 | 20 | 1,155 | 1,652 | $309,233 | $79,133 |
| 2021 | 21 | 1,204 | 1,722 | $229,665 | $108,628 |
| 2020 | 29 | 1,651 | 2,255 | $254,086 | $119,746 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 233 | 358 | $55,490 | $14,154 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 271 | $62,059 | $12,954 | 20.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 199 | $37,412 | $11,996 | 32.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 172 | 172 | $32,508 | $8,461 | 26.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 62 | $31,930 | $8,292 | 26.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 53 | 72 | $14,472 | $4,363 | 30.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 35 | 44 | $15,664 | $2,756 | 17.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 16 | $5,600 | $1,610 | 28.8% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 42 | 42 | $2,184 | $1,407 | 64.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 41 | $1,640 | $1,220 | 74.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 19 | $5,491 | $1,055 | 19.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 22 | $2,464 | $845.46 | 34.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 50 | 74 | $1,480 | $704.48 | 47.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 26 | $2,574 | $687.58 | 26.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 14 | $560.00 | $151.75 | 27.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 20 | $280.00 | $107.63 | 38.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 26 | 27 | $459.00 | $92.07 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 250 | 408 | $63,240 | $16,086 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 62 | 254 | $47,752 | $13,952 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 215 | $49,235 | $9,369 | 19.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 193 | 193 | $36,477 | $9,307 | 25.5% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 42 | 55 | $29,260 | $7,203 | 24.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 25 | $12,875 | $3,221 | 25.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 44 | 57 | $11,457 | $3,117 | 27.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 40 | 48 | $17,088 | $2,424 | 14.2% |
About Dr. Daniel Roney, M.D
Dr. Daniel Roney, M.D is a Family Medicine healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487618690.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Roney, M.D has received a total of $14,346 in payments from pharmaceutical and medical device companies, with $2,144 received in 2024. These payments were reported across 971 transactions from 79 companies. The most common payment nature is "Food and Beverage" ($14,270).
As a Medicare-enrolled provider, Roney has provided services to 5,039 Medicare beneficiaries, totaling 7,108 services with total Medicare billing of $378,364. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Kansas City, MO
- Active Since 04/14/2006
- Last Updated 08/24/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487618690
Products in Payments
- FARXIGA (Drug) $907.88
- VRAYLAR (Drug) $645.30
- JARDIANCE (Drug) $637.27
- Ozempic (Drug) $586.18
- VYVANSE (Drug) $484.99
- XARELTO (Drug) $430.33
- TRULICITY (Drug) $364.62
- UBRELVY (Drug) $361.81
- STIOLTO RESPIMAT (Drug) $328.30
- BREZTRI (Drug) $300.04
- SYMBICORT (Drug) $286.56
- Rybelsus (Drug) $283.93
- CHANTIX (Drug) $263.21
- NURTEC ODT (Drug) $241.90
- LYRICA (Drug) $233.40
- QULIPTA (Drug) $229.59
- TRELEGY ELLIPTA (Drug) $216.85
- LINZESS (Drug) $213.40
- ENTRESTO (Drug) $204.12
- ELIQUIS (Drug) $195.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kansas City
Dr. Meredith Levine, M.d, M.D
Family Medicine — Payments: $38,004
Eric Aspinwall, Md, MD
Family Medicine — Payments: $33,048
Dr. Maurice Blodgett, D.o, D.O
Family Medicine — Payments: $30,998
Dr. Blair Thedinger
Family Medicine — Payments: $19,784
Dr. Julie Alvarez, Md, MD
Family Medicine — Payments: $19,673
Teresa Marshall, M.d, M.D
Family Medicine — Payments: $19,051